SciELO - Scientific Electronic Library Online

 
vol.27 número1Chronic gallbladder wall thickening: Is it always malignancy?The efficacy of pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Em processo de indexaçãoSimilares em Google

Compartilhar


SA Journal of Radiology

versão On-line ISSN 2078-6778
versão impressa ISSN 1027-202X

S. Afr. J. radiol. (Online) vol.27 no.1 Johannesburg  2023

http://dx.doi.org/10.4102/sajr.v27i1.2595 

PICTORIAL REVIEW

 

Ultrasound and computed tomography in the evaluation of mesenteric lesions: A pictorial review

 

 

Snehal I. KoseI; Sapna SinghI; Anju GargI; Alpana ManchandaI; Rajdeep SinghII

IDepartment of Radiodiagnosis, Maulana Azad Medical College, Delhi, India
IIDepartment of Surgery, Maulana Azad Medical College, Delhi, India

Correspondence

 

 


ABSTRACT

The mesentery is a broad fan-shaped fold of peritoneum that suspends the loops of small intestine from the posterior abdominal wall. Although primary neoplasms arising in the mesentery are rare, the mesentery is a major avenue for the dissemination of tumours, which can spread through hematogenous, lymphatic, direct or peritoneal seeding. Imaging helps in the diagnosis of these tumours and aids in directing appropriate treatment by assessing their size, extent and relationship with adjacent structures. The aim of this article is to describe the spectrum of imaging findings of the various mesenteric lesions using ultrasound and CT.
CONTRIBUTION: Evaluation of the mesentery is often neglected during routine ultrasound (US) because of inadequate training and unfamiliarity with the common US features encountered with mesenteric disease. CT plays an essential role in the diagnosis of mesenteric disease. Knowledge of imaging characteristics of various mesenteric lesions helps in timely diagnosis and management.

Keywords: CT; computed tomography; ultrasound; inflammatory myofibroblastic tumour; gastrointestinal stromal tumour.


 

 

Introduction

The mesentery is a broad, fan-shaped fold of peritoneum that suspends the loops of small intestine from the posterior abdominal wall. Secondary involvement of the mesentery from tumours elsewhere is much more common than primary mesenteric neoplasms such as desmoid tumour, inflammatory myofibroblastic tumour (IMFT), and others. Most patients with mesenteric lesions present with non-specific symptoms of abdominal pain, tenderness, palpable abdominal swelling, abdominal distension and weight loss. These symptoms are shared by pathologies of other abdominal organs and it is therefore very difficult to identify mesenteric lesions clinically.

Some mesenteric diseases present with distinctive imaging findings while others have similar findings, thereby complicating their differential diagnosis. Understanding the characteristic radiological patterns on ultrasound (USG) and CT offers valuable insights for differential diagnoses of mesenteric lesions and their treatment.

 

Primary solid mesenteric lesions

Primary mesenteric solid neoplasms are rare and the majority of them are benign.

Desmoid tumour

The most common soft tissue lesion in the mesentery is a desmoid tumour. It usually occurs in patients with familial adenomatous polyposis (FAP) or Gardner syndrome. Trauma or surgery serves as a predisposing factor for the development of desmoid tumours.1 On USG, this tumour appears as a well-defined or ill-defined mass with heterogenous echotexture and internal vascularity. On CT, it appears as a well-defined or ill-defined mass showing heterogenous enhancement usually in the portal venous phase and it may infiltrate the adjacent organs.2 The MRI appearance of desmoid tumours depends on the relative proportion of cellular, myxoid and fibrous components.

Inflammatory myofibroblastic tumour

Inflammatory myofibroblastic tumours usually occur in children and adolescents. They appear as solitary or multiple irregular hypoechoic masses with heterogeneous echotexture and increased echogenicity in the surrounding mesentery and omentum on USG and show increased internal vascularity on colour Doppler.3 Inflammatory myofibroblastic tumour appears as a hypo or iso-attenuating mass compared with skeletal muscle depending on the amount of myxoid or collagenous stroma, respectively. Dense central calcification may be noticed. They demonstrate various contrast enhancement patterns including early peripheral enhancement because of vascular tissue (Figure 1), delayed central enhancement of the fibrotic components, heterogenous, homogenous and absent enhancement.4 Differential diagnosis includes desmoid tumour and solitary fibrous tumour.

Lipoma and liposarcoma

Lipomas are benign tumours composed of mature adipose tissue, usually associated with obesity and hyperlipidaemia. On USG, they appear as well-defined echogenic lesions without internal vascularity. On CT, they appear as a well encapsulated fatty attenuation mass. Differential diagnosis includes well-differentiated liposarcoma, which is characterised by larger size (usually greater than 10 cm), associated soft tissue component and thick irregular septations. Liposarcomas are rare malignant tumours of the mesentery. Liposarcomas are divided into five types histopathologically: well-differentiated, myxoid, pleomorphic, round cell and de-differentiated liposarcoma. Well-differentiated liposarcomas have mixed fatty and soft tissue components while de-differentiated liposarcomas have clearly separated soft tissue and fatty components. Myxoid liposarcomas have fluid density on CT with mixed soft tissue and fatty components. Pleomorphic and round cell liposarcomas have soft tissue components only, with no identifiable fatty component on imaging.

Mesenteric Castleman disease

Three patterns of mesenteric involvement have been described for Castleman disease, namely a solitary non-invasive mass (most common), a dominant infiltrative mass with associated lymphadenopathy and matted lymphadenopathy without a dominant mass. These tumours show early, homogenous and intense enhancement (Figure 2). Tumours measuring > 5 cm in size may show heterogenous enhancement. Calcification is seen in 10% of cases, which can be punctate or arborising in appearance. The arborising type of calcification (Figure 2) is characteristic of Castleman disease.5

Calcifying fibrous tumour of the mesentery

Calcifying fibrous tumours appear as round hypo or hyperdense masses on CT with various patterns of calcification: irregular, scattered, punctate, band-like, clustered and amorphous6 (Figure 3).

Malignant mesothelioma

Malignant mesotheliomas tend to spread as sheets of tissue over the parietal and visceral peritoneal surfaces and become confluent, encasing the abdominal organs (Figure 4). The 'wet' type presents as an irregular, nodular or sheet-like peritoneal thickening, omental mass and ascites while in the 'dry' type, peritoneal based masses are present with no ascites.7 Imaging presentation of this tumour is similar to peritoneal carcinomatosis. The presence of asbestos exposure, calcified pleural plaques and relatively less ascites compared with soft tissue burden, favours the diagnosis of malignant mesothelioma over peritoneal carcinomatosis.

Primary mesenteric gastrointestinal stromal tumour

Extraintestinal gastrointestinal stromal tumours usually appear as well-defined masses with lobulated contours. They usually reveal heterogenous enhancement with central low attenuation areas occupying more than half of the tumour area (Figure 5) and increased peripheral attenuation. Central gas or extravasation of oral contrast may be seen due to communication of the mass with the bowel lumen.8 Calcification and lymphadenopathy are usually not present.

Sclerosing mesenteritis

Mesenteric panniculitis presents as a well-defined fatty mass in the root of mesentery. Diffuse homogenous hyperechogenicity with good sound transmission through it and non-deviated vessels is seen on ultrasound. It appears as a well-defined mass of inhomogenous fatty tissue encasing the superior mesenteric vessels with no invasion of surrounding bowel loops on CT (Figure 6). Well-defined soft tissue nodules with preservation of fatty halo around vessels and nodules (fat ring sign) may be seen. Hyperattenuating stripe partly surrounding the mass (tumoural pseudocapsule sign) is seen in 59.2% cases.9

Retractile mesenteritis (sclerosing mesenteritis with predominant fibrotic component) is seen as one or more irregular fibrotic soft tissue mesenteric masses7, which may show calcification within and may encase adjacent bowel loops and vascular structures leading to signs of obstruction and hollow visceral ischaemia. An important differential for sclerosing mesenteritis is mesenteric metastases from carcinoid tumour, which also presents as a spiculated marginated mass in the mesentery; however, associated arterial phase hyperenhancing small bowel thickening is usually seen in carcinoid metastases.

Primary cystic mesenteric lesions

Lymphangiomas

Lymphangiomas are benign lymphatic proliferations that usually occur in childhood. They appear as thin-walled cystic lesions with multiple thin septa (honeycomb or cobweb pattern) on USG and as a unilocular or multilocular cyst with enhancement of the wall or septations on contrast enhanced CT.10 They show variable attenuation depending on their contents (chylous, serous or haemorrhagic contents) and may insinuate between the mesenteric vessels (Figure 7).

Simple mesothelial cysts

These appear as thin-walled anechoic unilocular cysts with posterior acoustic enhancement on USG and unilocular fluid attenuation lesions with no discernible wall on CT.11

Benign cystic mesothelioma

Benign cystic mesotheliomas are also known as peritoneal inclusion cysts and they usually occur in premenopausal women. They are often associated with trauma, surgery, infection and endometriosis.2 They occur because of entrapment of fluid (secreted by the ovaries during ovulation) between peritoneal adhesions.7 They are seen as a fluid attenuation multilocular cystic lesion, multiple unilocular thin-walled cysts or unilocular cystic mass on CT with enhancing but non-calcified septa, which often surround the ovaries. On USG, they appear as unilocular or multilocular cystic lesions, which may be anechoic or may display contents of variable echogenicity (Figure 8).

Benign mucinous cystic neoplasm of the mesentery

They usually arise from implantation of ovarian tissue during migration or metaplasia of mesothelial cells into ovarian tissue. They appear as thin-walled fluid attenuation unilocular cystic lesions in the mesentery (Figure 9).

Secondary mesenteric lesions

Secondary involvement of the mesentery by tumours elsewhere is much more common than primary mesenteric tumours. These neoplasms spread to the mesentery by the following routes:

Direct tumour spread

Several abdominal malignancies including biliary, pancreatic, gastric and colon cancers may invade directly into the mesentery.12

Direct spread into the mesentery occurs in small bowel carcinoid, which appears as an intensely enhancing soft tissue mass with linear fibrous bands radiating in the surrounding fat. Calcification occurs in 70% cases.13 Associated thickening of the bowel wall and angulation of bowel loops might be noticed (Figure 10).

Lymphatic spread

Lymphoma appears as a lobulated sonolucent mass surrounding vascular trunks with maintained perivascular echogenic fat giving the 'sandwich appearance'.14 Lymph nodes may be small and discrete in early disease and later coalesce to form a conglomerate soft tissue mass, which grows around and displaces surrounding structures. Involved lymph nodes have soft tissue attenuation (40 HU - 50 HU) and demonstrate homogeneous enhancement following contrast administration (Figure 11). Besides lymphoma, many other tumours such as lung, breast, colon, ovarian cancers, chronic lymphoid leukaemia, and others, can involve the mesentery via the lymphatics.

Hematogenous spread

Melanoma, breast and lung carcinoma can involve the mesentery via the hematogenous route.12 These lesions are usually seen along the antimesenteric border because of the abundant submucosal vascular plexus.

Four patterns of peritoneal seeding are noted:12

Infiltrative pattern leading to a misty mesentery.

Nodular pattern/caking (Figure 12).

Retractile pattern seen as small bowel retraction, angulation and kinking.

Stellate mesentery: The straightened mesenteric blood vessels are held rigid within a thickened sheet such as the mesentery, producing the characteristic stellate appearance on CT because of infiltration of tumour along the mesenteric vessels.

Infections

Abdominal tuberculosis

Abdominal lymphadenopathy is the most common finding associated with tuberculosis. Involved lymph nodes appear enlarged, conglomerate and show ring enhancement (necrosis). Other findings observed in cases of abdominal tuberculosis include mesenteric nodularity, fat stranding, peritoneal thickening, localised collections, free fluid, clumping of bowel loops, bowel wall thickening and solid organ involvement in the form of hepatomegaly, splenomegaly, liver and splenic granulomas.15

Whipple's disease

It is an infectious condition caused by Gram-positive bacterium, Tropheryma whipplei. On imaging, small bowel wall thickening associated with enlarged mesenteric lymph nodes demonstrating hypoattenuating centres because of fat deposition can be seen. Diagnosis is made by small intestinal mucosal biopsy.16

Actinomycosis

Actinomyces israelii is an anaerobic Gram-positive bacterium and is a normal inhabitant of the oral cavity, gastrointestinal tract and female genital tract. It spreads to involve the mesentery when a mucosal breach is present such as inflammation, surgery, trauma or intrauterine contraceptive device (IUCD) use.17 On imaging, an ill-defined heterogeneously enhancing soft tissue mass infiltrating the mesentery and adjacent organs can be seen. Septic embolism leading to hepatic, renal and splenic abscesses can occur.2 Diagnosis is made based on aggressive imaging features and subtle clinical symptoms in predisposed individuals. Biopsy should be performed in indeterminate imaging findings, which reveal sulphur granules representing bacterial colonies.

Hydatid cyst

These usually occur because of intraperitoneal rupture of liver or splenic hydatid cysts (Figure 13). Hydatid cysts can appear as either unilocular cysts (Type I cyst), multiloculated cystic lesions with daughter cysts at the periphery (type IIA), multilocular lesions with irregular daughter cysts occupying almost the entire volume of the maternal cyst (rosette appearance - type IIB) or high attenuation lesion containing occasional calcification and daughter cysts (type IIC). Type III cysts are calcified cysts while complicated hydatid cysts are included in the type IV category.18

Inflammatory bowel disease

Mesenteric changes in inflammatory bowel disease include mesenteric fibrofatty proliferation, mesenteric lymphadenopathy, fat stranding (Figure 14), abscess and prominent vasa recta (Comb sign).

Vascular anomalies

Acute mesenteric ischaemia

Findings in acute mesenteric ischaemia related to superior mesenteric artery (SMA) thrombosis include dilated bowel loops with paper-thin walls, pneumatosis intestinalis, air within mesenteric vessels, mesenteric fat stranding and free fluid on CECT19 (Figure 15).

SMA-SMV arteriovenous fistula

On USG, tangled serpentine vessels can be seen, which show pulsatile waveforms on spectral doppler while on CECT, tangled serpentine vessels can be seen with early opacification of venous channels in the arterial phase. Direct communication between branches of the SMA and superior mesenteric vein (SMV) can be visualised on volume rendering technique (VRT) images.

Role of imaging

Ultrasound is the primary imaging modality in the evaluation of mesenteric lesions. It helps in characterising mesenteric lesions as solid or cystic. Ultrasound guided percutaneous biopsy offers real time assessment of the needle tract to avoid vascular injury while performing biopsy.20 Evaluation of lesions is limited on USG because of operator-dependence, obscuration of the mass in the presence of a gaseous abdomen and obese patients, and inadequate visualisation of the extent of large mesenteric lesions. Contrast enhanced CT is the primary workhorse for evaluation of mesenteric lesions. It helps in determining the origin of the lesions, providing thoughtful differential diagnosis of masses, for selecting the site of biopsy, determining the extent of pathology and accessibility for resectability of lesion. CT, however, has several limitations including poor soft tissue contrast resolution, exposure to ionising radiation and contrast reactions. MRI can be used as the next step in characterising mesenteric lesions. It has higher soft tissue contrast resolution and helps in characterising fluid content of cysts as serous, mucinous, chylous or haemorrhagic and the soft tissue component of solid lesions. Fluoro-deoxyglucose (FDG) positron emission tomography (PET) CT is presently used to detect lymph nodes and distant metastases in mesenteric tumours and also for response assessment to chemotherapy.

Management of mesenteric lesions

Management of mesenteric lesions depends on symptoms and imaging findings. Mesenteric lesions detected incidentally on imaging need classification as benign or malignant. Definite diagnosis of a few pathologies such as mesenteric panniculitis, lymphoma, desmoid tumour in patients with FAP and benign cystic lesions can be made on imaging. However, lesions with indeterminate imaging findings need to be biopsied to rule out malignancy. Imaging helps in determining the site for percutaneous biopsy in such tumours. Lesions that are inaccessible to percutaneous biopsy or show indeterminate histopathology findings on percutaneous biopsy require surgical biopsy to confirm the diagnosis.21

Once confirmed by biopsy, management of the mesenteric lesions depends on the histopathology. Lymphomas and desmoid tumours are managed conservatively with chemotherapy and hormonal therapy or imatinib, respectively. Well-circumscribed lesions located in the periphery of the mesentery can be resected completely, without sacrificing significant bowel length or major mesenteric vessels. Infiltrative mesenteric lesions, located in the root of mesentery are usually managed conservatively because of involvement of major vessels and the need for sacrificing a major portion of bowel, which may lead to small bowel syndrome. Well-defined malignant tumours and symptomatic benign tumours are treated surgically. The goal of surgery is R0 resection (grossly as well as microscopically negative tumour margins), while R1 resection followed by adjuvant chemoradiotherapy can also be performed. Well-defined asymptomatic benign lesions can be followed up and resection is performed when they become large or cause symptoms. Symptomatic infiltrative benign or malignant lesions can be managed by debulking surgery to reduce tumour load and prevent complications such as bowel obstruction or mesenteric ischemia.

 

Conclusion

Although histopathology is the gold standard for diagnosis of mesenteric lesions, imaging plays an important role in diagnosis of mesenteric neoplasms, detection of complications and in deciding appropriate treatment options. Ultrasound is inadequate for optimal visualisation of mesenteric neoplasms and in detecting their relation with other structures because of shadowing from bowel gas, calcification or inadequate penetration of sound beams in obese patients. CT is an excellent imaging modality in the characterisation of mesenteric lesions, detecting their extent and relations with surrounding structures, which is useful for surgical planning. However, CT too has several limitations and other imaging modalities such as MRI and FDG-PET can be helpful in further characterisation of mesenteric lesions.

 

Acknowledgements

Competing interests

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Authors' contributions

S.K. conceptualised this article. S.S., A.G. and A.M. supervised the data collection. S.S., A.G., A.M. and R.S. reviewed and edited the final draft of the manuscript. S.K. collected the relevant data and reference articles and prepared the primary manuscript draft.

Ethical considerations

Ethical clearance to conduct this study was obtained from the Maulana Azad Medical College (reference: F.No. 17/IEC/MAMC/2018/17).

Funding information

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Data availability

The authors confirm that the data supporting the findings of this study are available within the article.

Disclaimer

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any affiliated agency of the authors.

 

References

1.Shields CJ, Winter DC, Kirwan WO, Redmond HP. Desmoid tumours. Eur J Surg Oncol. 2001;27(8):701-706. https://doi.org/10.1053/ejso.2001.1169        [ Links ]

2.Dufay C, Abdelli A, Le Pennec V, Chiche L. Mesenteric tumors: Diagnosis and treatment. J Visc Surg. 2012;149(4):e239-e251. https://doi.org/10.1016/j.jviscsurg.2012.05.005        [ Links ]

3.Qian J, Zhu K, Ye J. Ultrasonic manifestations of mesenteric inflammatory myofibroblastic tumors in children. Front Pediatr. 2019;7:39. https://doi.org/10.3389/fped.2019.00039        [ Links ]

4.Chung EM, Biko DM, Arzamendi AM, Meldrum JT, Stocker JT. Solid tumors of the peritoneum, omentum, and mesentery in children: Radiologic-pathologic correlation. Radiographics. 2015;35(2):521-546. https://doi.org/10.1148/rg.352140273        [ Links ]

5.Bonekamp D, Horton KM, Hruban RH, Fishman EK. Castleman disease: The great mimic. Radiographics. 2011;31(6):1793-1807. https://doi.org/10.1148/rg.316115502        [ Links ]

6.Chorti A, Papavramidis TS, Michalopoulos A. Calcifying fibrous tumor: Review of 157 patients reported in international literature. Medicine. 2016;95(20):e3690. https://doi.org/10.1097/MD.0000000000003690        [ Links ]

7.McLaughlin PD, Filippone A, Maher MM. Neoplastic diseases of the peritoneum and mesentery. Am J Roentgenol. 2013;200(5):W420-W430. https://doi.org/10.2214/AJR.12.8494        [ Links ]

8.Kim HC, Lee JM, Kim SH, et al. Primary gastrointestinal stromal tumors in the omentum and mesentery: CT findings and pathologic correlations. Am J Roentgenol. 2004;182(6):1463-1467. https://doi.org/10.2214/ajr.182.6.1821463        [ Links ]

9.Daskalogiannaki M, Voloudaki A, Prassopoulos P, et al. CT Evaluation of mesenteric panniculitis: Prevalence and associated diseases. Am J Roentgenol. 2000;174(2):427-431. https://doi.org/10.2214/ajr.174.2.1740427        [ Links ]

10.Gunasekaran G, Naik D, Kandhasamy SC, Soren DN. Giant mesenteric cystic lymphangioma: A rare cause of intra-abdominal catastrophe. Int Surg J. 2019;6(11):4184-4186. https://doi.org/10.18203/2349-2902.isj20195152        [ Links ]

11.Ros PR, Olmsted WW, Moser RP, Dachman AH, Hjermstad BH, Sobin LH. Mesenteric and omental cysts: Histologic classification with imaging correlation. Radiology. 1987;164(2):327-332. https://doi.org/10.1148/radiology.164.2.3299483        [ Links ]

12.Nougaret S, Lakhman Y, Reinhold C, et al. The wheel of the mesentery: Imaging spectrum of primary and secondary mesenteric neoplasms - How can radiologists help plan treatment?: Resident and fellow education feature. RadioGraphics. 2016;36(2):412-413. https://doi.org/10.1148/rg.2016150186        [ Links ]

13.Sheth S, Horton KM, Garland MR, Fishman EK. Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis. Radiographics. 2003;23(2):457-473. https://doi.org/10.1148/rg.232025081        [ Links ]

14.Mueller PR, Ferrucci Jr, JT, Harbin WP, Kirkpatrick RH, Simeone JF, Wittenberg J. Appearance of lymphomatous involvement of the mesentery by ultrasonography and body computed tomography: The 'sandwich sign'. Radiology. 1980;134(2):467-473. https://doi.org/10.1148/radiology.134.2.7352232        [ Links ]

15.Burrill J, Williams CJ, Bain G, Conder G, Hine AL, Misra RR. Tuberculosis: A radiologic review. Radiographics. 2007;27(5):1255-1273. https://doi.org/10.1148/rg.275065176        [ Links ]

16.Misbah SA, Aslam A, Costello C. Whipple's disease. Lancet. 2004;363(9409):654-656. https://doi.org/10.1016/S0140-6736(04)15600-6        [ Links ]

17.Pusiol T, Morichetti D, Pedrazzani C, Ricci F. Abdominal- pelvic actinomycosis mimicking malignant neoplasm. Infect Dis Obstet Gynecol. 2011;2011:747059. https://doi.org/10.1155/2011/747059        [ Links ]

18.Mehta P, Prakash M, Khandelwal N. Radiological manifestations of hydatid disease and its complications. Trop Parasitol. 2016;6(2):103-112. https://doi.org/10.4103/2229-5070.190812        [ Links ]

19.Florim S, Almeida A, Rocha D, Portugal P. Acute mesenteric ischaemia: A pictorial review. Insights Imaging. 2018;9:673-682. https://doi.org/10.1007/s13244-018-0641-2        [ Links ]

20.Lee JK, Baek SY, Lim SM, Lee KH. Reticular infiltrations alone without mass in the mesentery and omentum identified at contrast-enhanced CT: Efficacy of US-guided percutaneous core biopsy. Radiology. 2011;261(1):311-317. https://doi.org/10.1148/radiol.11103523        [ Links ]

21.Gottlieb RH, Tan R, Widjaja J, et al. Extravisceral masses in the peritoneal cavity: Sonographically guided biopsies in 52 patients. Am J Roentgenol. 1998;171(3):697-701. https://doi.org/10.2214/ajr.171.3.9725299        [ Links ]

 

 

Correspondence:
Snehal Kose
kosesnehal@gmail.com

Received: 22 Nov. 2022
Accepted: 22 Mar. 2023
Published: 24 May 2023

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons